Filing metadata

Accession number
0001493152-24-038029
Form type
Form 3
Filer
Kairos Pharma, LTD.
CIK
CIK 1962011
Filed
Sep 24, 2024
Reporting period
Sep 16, 2024
Description
Initial ownership

Explore SEC Filings Hub